glp-1 research studies The Clinical Trial Landscape in 2024 The GLP-1 revolution: What UAB

A 2025 meta-analysis published in Endocrinology, Diabetes & Metabolism, pooling data from four studies with nearly 29,000 patients, confirmed a consistent advantage for tirzepatide, with an average additional weight reduction of 4.84 kg compared to semaglutide

Statements Author contributions JM wrote the paper with input from AV regarding content and layout

Efficacy and safety of onceweekly semaglutide 1.0 mg vs oncedaily liraglutide 1.2 mg as addon to 13 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)

People with a personal or family history of certain thyroid cancers should talk to their healthcare provider

This baseline becomes the before in your before and after story

Moreover, no significant alterations were detected in the expression of gluconeogenesis-related enzymes PCK1 and G6PC (Supplementary Fig